Federation des caisses Desjardins du Quebec’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-27,978
Closed -$64.7K – 2984
2025
Q2
$64.7K Buy
27,978
+5,197
+23% +$12.7K ﹤0.01% 1482
2025
Q1
$32.6K Sell
22,781
-259
-1% -$433 ﹤0.01% 1578
2024
Q4
$41.6K Sell
23,040
-62,446
-73% -$84.9K ﹤0.01% 1466
2024
Q3
$105K Sell
85,486
-7,526
-8% -$10.2K ﹤0.01% 1251
2024
Q2
$129K Buy
93,012
+48,456
+109% +$64.3K ﹤0.01% 1196
2024
Q1
$94.5K Sell
44,556
-9,758
-18% -$15.7K ﹤0.01% 1253
2023
Q4
$87.3K Buy
54,314
+4,625
+9% +$6.97K ﹤0.01% 1159
2023
Q3
$104K Buy
+49,689
New +$106K ﹤0.01% 1114

Other funds holding THTX

Federation des caisses Desjardins du Quebec's THTX Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 27,978 shares — an estimated $64.7K sold.

Federation des caisses Desjardins du Quebec first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $129K in Q2 2024. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 27,978 Theratechnologies shares in Q3 2025, an estimated $64.7K.
  • Federation des caisses Desjardins du Quebec first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Federation des caisses Desjardins du Quebec's Theratechnologies position peaked at $129K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.